IBM to funnel $240M into new AI lab at MIT

IBM plans to invest $240 million over the next 10 years to create a Watson-focused artificial intelligence lab in collaboration with Cambridge-based Massachusetts Institute of Technology.

Advertisement

The MIT-IBM Watson AI Lab will support more than 100 scientists, professors and students in AI research related to four pillars: AI algorithms, physics of AI, application of AI to industries and “advancing shared prosperity through AI,” according to an IBM statement. Under the partnership, IBM will encourage researchers to collaborate with its research lab in Cambridge, which includes both IBM Watson Health and IBM Security headquarters.

Dario Gil, PhD, IBM’s vice president of AI and IBM Q, and Anantha P. Chandrakasan, dean of MIT’s school of engineering, will co-chair the lab.

More articles on artificial intelligence:

Analysis: Watson for Oncology was over-marketed, now underwhelms hospitals and oncologists

Elon Musk: Governments will take extreme measures to obtain AI technology

Sutter Health, Qventus partner to deploy AI-based pharmacy platform

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.